PDI EXPANDS CONTRACT WITH DENDRITE

Dendrite International, Inc. (NASDAQ: DRTE) a leading provider of sales, marketing, clinical, and compliance solutions for the pharmaceutical and life sciences industry and PDI, Inc. (NASDAQ: PDII), a diversified sales and marketing services provider to the biopharmaceutical, medical devices and diagnostics industries, today announced that PDI has extended its previously announced product and services contract with Dendrite. The extended contract will now provide PDI's dedicated sales teams with Dendrite's leading technologies for optimizing and coordinating promotional activities.

PharmaLive (http://www.pharmalive.com/News/index.cfm?articleid=261195&categoryid=22)